Conti Profits Dive on Special Charges
Continental AG’s revenue for the third quarter rose 4% to €10 billion ($10.9 billion). But special charges dragged down pretax earnings 42% to €596 million ($650 million).
#economics
Continental AG’s revenue for the third quarter rose 4% to €10 billion ($10.9 billion). But special charges dragged down pretax earnings 42% to €596 million ($650 million).
Separately, the tires and electronics supplier predicts widespread exchange-rate turmoil for the auto industry because of U.S. president-elect Donald Trump’s threats to levy tariffs on vehicles imported from Mexico. “The whole industry uses Mexico as an export country to the U.S., “ Chief Financial Officer Wolfgang Schaefer tells Bloomberg News.
Conti’s net income for July-September sagged to €379 million ($413 million) from €1 billion in the same period last year. Results were hurt by €450 million ($490 million) in costs in its automotive operations related to warranty claims, an impending antitrust settlement and product research, according to the company.
Still, the company is bullish about a strong finish in the fourth quarter, including a 10.5% margin for adjusted EBIT.
RELATED CONTENT
-
on the Genesis GV60 interior, EV sales in H1, Bentley Bentayga's wood work, Faurecia's advanced manufacturing & more
The strange glowing orb in the Genesis GV60. . .global EV sales in the first half. . .creating wood for the Bentayga interior. . .the importance of material handling at Faurecia. . .lux ATPs. . .fast Porsche. . .fast Lambo. . .the Avalon Hybrid. . .Silverado steel. . .
-
Enterprise Edges into Self-Driving Car Market
U.S. rental car giant Enterprise Holdings Inc. is the latest company to venture into the world of self-driving vehicles.
-
On Global EV Sales, Lean and the Supply Chain & Dealing With Snow
The distribution of EVs and potential implications, why lean still matters even with supply chain issues, where there are the most industrial robots, a potential coming shortage that isn’t a microprocessor, mapping tech and obscured signs, and a look at the future